Altimmune (ALT) Current Taxes (2016 - 2022)
Altimmune (ALT) posted quarterly Current Taxes of $1.2 million for Q3 2022, down 62.98% quarter-over-quarter from $3.2 million in Q4 2016.
Altimmune (ALT) Current Taxes (2016 - 2022) Analysis & Trends
Altimmune (ALT) has reported Current Taxes for 2 consecutive years, with $1.2 million the latest figure, recorded in Q3 2022.
- In Q3 2022, Current Taxes changed N/A year-over-year to $1.2 million; the TTM figure through Sep 2022 stood at $1.2 million (changed N/A YoY), while the FY2016 annual figure was $3.2 million, changed N/A from the prior year.
- Current Taxes fell to $1.2 million in Q3 2022 per ALT's latest filing, from $3.2 million in the prior quarter.
- Across five years, Current Taxes topped out at $1.2 million in Q3 2022 and bottomed at $1.2 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.17 Mn |
| Dec 31, 2016 | 3.16 Mn |